Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia

The BNA provides clinicians and researchers with an efficient and reliable means by which to evaluate global neurocognitive impairments in patients with schizophrenia by allowing estimation of performance on a more comprehensive standardized battery.